
SWEDEN - EQT and Investor AB sells Gambro Health Care to Bridgepoint
Investor AB and EQT has agreed to sell Gambro Health Care to Bridgepoint for an undisclosed sum from Gambro Holding AB. Prior to the sale EQT has held a 51% stake in the company, and Investor AB held the remaining. The sale of Gambro Healthcare is part of the value creation plan which has been implemented since Investor AB and EQT acquired the Gambro Holding AB in June 2006. The divestiture of the clinics will allow greater focus on driving further value creation in Gambro Renal Products as well as Gambro BCT, while Gambro Healthcare can accelerate its development with the new owner.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater